Oxy Watchdog

Keeping An Eye On OxyContin

Makers of OxyContin suppress generic brands

Posted by Oxy Watchdog on August 24, 2010

Australian company Mundipharma is fighting patents on generic forms of oxycodone, which if brought to market would drastically cut the pharmaceutical company’s profits of OxyContin, reports the American Chronicle. Oxycodone is the highest selling opiate in Australia, with reported sales of $42 million in 2009.  A similar situation is echoed with the U.S. manufacturer of OxyContin, Purdue Pharma LP, which recently submitted a new patent for the reformulated version of the painkiller. The new patent ensures other companies will not be able to create generic forms of oxycodone, reports ABC News.

Information on Purdue Pharam’s reformulated version of OxyContin can be found here.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: